(Q43598571)

25 November 2017

title

The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

25 November 2017

main subject

0 references

0 references

0 references

1 reference

Liebman HA

1

1 reference

25 November 2017

Kashani N

2

1 reference

25 November 2017

Sutherland D

3

1 reference

25 November 2017

McGehee W

4

1 reference

25 November 2017

Kam AL

5

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

25 November 2017

1 reference

25 November 2017

volume

115

1 reference

25 November 2017

issue

4

1 reference

25 November 2017

page(s)

830-834

1 reference

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Vascular complications of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Evidence for activation of coagulation in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Circulating von Willebrand factor in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Resistance to activated protein C as a basis for venous thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Mutation in blood coagulation factor V associated with resistance to activated protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Activated protein C resistance caused by Arg506Gln mutation in factor Va

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Excessive fibrinolysis in amyloidosis associated with elevated plasma single-chain urokinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Clarifying the causes of Crohn's

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Acquired protein C and S deficiency, inflammatory bowel disease and cerebral arterial thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Free protein S deficiency in patients with Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Deep venous thrombosis, inflammatory bowel disease, and protein S deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

World distribution of factor V Leiden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

Response to heparin in patients with ulcerative colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970253-7

10.1016/S0016-5085(98)70253-7

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference